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The results of glucagone test carried out on 10 patients with acute viral 
hepatitis (A VH) were presented and discussed. A delayed glucose liver release 
was established that indicated the disturbed glycogenosis (destructed 
membrane structures and enzyme dysfunction) along with reduced glycogen 
amounts in AVH. A decreased intensity of insulin response to glucagone 
stimulation was found out. The importance of the incorporation of the 
glucagone test into liver function evaluation in AVH was demonstrated. 
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INTRODUCTION 
Liver contribution to the steady glucose 
level in circulation is mainly due to the 
ability of hepatic cells to process glycogen 
and to synthesize glucose from 
noncarbohydrate substances. The glycogen 
amount in hepatocytes provides an 
important evidence of this liver activity. 
Glycogen reserve is determined by the ratio 
between its synthesis rate and degradation 
rate. 
Discrepant data about liver glycogen 
quantity in patients with acute viral 
hepatitis (AVH) have been reported by 
now. Some authors have found lower 
Address for correspondence: 
Assoc. Prof. M. Nenova, Dept. of Infectious 
Diseases, Medical University, Varna, 
55 Marin Drinov St, BG 9002 Varna, BULGARIA 
glycogen liver amounts (1) while others 
have established a glycogen elevation in 
polyploid cells increasing parallelly to the 
extension of parenchymatous damage (5). 
Non-invasive methods for glycogen reserve 
assessment have been always preferred to 
in A V H patients, since liver biopsy is 
undertaken only in cases of suspected liver 
disorders of different nature. Loading with 
glucagone is considered such an 
appropriate method. Glucagone possesses 
two independent properties: on the one 
hand, it stimulates glycogenolysis in the 
liver resulting in an enhancement of serum 
glucose level, and, on the other hand, it 
stimulates insulin release from pancreatic 
B-cells (4). 
The present study was designed to 
assess the liver glycogen reserve by means 
of glucagone test in A V H patients. 
Therefore, the following aims were set: 
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Blood glucose hy glucagone test. 
1. To evaluate serum glucose fasting 
prior to and after glucagone loading in 
A V H patients. 
2. To estimate the immunoreactive 
insulin ( IRI) after glucagone stimulation in 
the same patients. 
M A T E R I A L AND METHODS 
Ten patients with advanced A V H (8 
lies and 2 females) aged 38,4 ± 11,4 
ears with mean duration of hospitalization 
f 33,8 ± 5,9 days were examined. A 
positive HBsAg-test was proved in four 
patients. A course of average severity was 
ollowed-up in all cases: mean bilirubin of 
78.50 ±21 ,26 цто1/1; A L A T of 654,00 ± 
211,10 IU , McLagan test raised up to 
25,45 SHU. Total serum proteins and 
haemostasis parameters were estimated to 
be within reference values. All patients 
vere of normal weight and without any 
glucocorticosteroid treatment. 
Five healthy volunteers (3 females and 
2 males) of the mean age of 39,0 ± 5,0 
years served as controls. 
The experiments were performed in the 
morning. After measuring fasting serum 
glucose and separating a serum sample for 
I R I test, an intravenous 2 min infusion of 1 
ml glucagone was administered. Blood 
samples were taken 10, 30, 60, and 120 
10 20 30 40 50 60 70 80 90 100 110 120 
Fig. 2. IRI hy glucagone test 
to min after the glucagone application 
estimate serum glucose and I R I . 
Serum glucose was determined by the 
enzyme GDD-PAP Assay (Randox Labs. 
Int.). I R I was evaluated by a set of 
radioimmunologic techniques based on the 
double-antibody method (Rotor RIA) . The 
variables were statistically processed by 
means of the multivariate analysis. 
RESULTS 
The results from the glucagone test are 
demonstrated on Table 1 as well as on Fig. 
1 and Fig. 2. 
A mean elevation of serum glucose by 
1,48 ± 0,54 mmol/1 within 10 min after 
glucagone application in healthy controls 
was established while it is only by 0,91 ± 
0,50 mmol/1 at the same time in A V H 
patients as the peak level was not reached 
until the 30*h min after glucagone infusion 
(t = 2,14; p < 0,05). An increase of I R I 10 
min after glucagone stimulation was 
measured in the control group (77,00 ± 
0,54 ци/ml) and in A V H patients (33,00 ± 
16,82 ци/ml). Insulin level began to 
decrease about 30 min after glucagone 
administration in both groups and 
normalized at the end of the test. 
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Parameter Tested Fasting After 10 mm After 30 min After 60 mm After 120 mm 
persons x ± o x ± a x ± a x ± a x ± a 
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Table 1 
Serum glucose and I R I levels after glucagone stimulation in AVH patients 
Serum AVH 
glucose Controls 









































It was found out that glucagone 
application resulted in a slighter serum 
glucose elevation in A V H patients as 
compared to that in healthy individuals. 
This indicated a delayed liver glucose 
release due to the disturbed glycogenolysis. 
Statistically significant differences were 
proved for the 10^ min samples only 
which implied that a reduced liver glycogen 
reserve in A V H patients was not the most 
probable cause for poor glucose release. 
Furthermore, some authors (5) reported a 
tendency towards glycogen influx in 
necrotic and regeneration areas of 
hepatocytic population from liver biopsy of 
A V H patients by means of visualizing 
cytochemical assays. This finding was 
considered a result of the great 
compensatory capacity of the liver to retain 
glycogen reserve in cases of more severe 
parenchymatous lesions. Critical 
parenchymal volume permitting liver 
functioning was considered to be about 28-









hepatocytes was maintained by 
regenerating cells (3). 
Therefore, in our opinion, the delayed 
liver glucose release in A V H patients is due 
to several causes such as disturbances of 
ferment cascades activating phosphorylase 
(2, 7, 8), diminished glucose-6-phosphatase 
activity depending on the membrane lipids 
and membrane integrity, as well as (partly) 
reduction of liver glucogen storage (6, 9). 
A decrease of insulin B-cell response to 
glucagone stimulation was also found out. 
The difference of I R I values was 
considerable at the l()th min of the trial 
only thus a suppression of B-cell activity 
was suggested as the rapid insulin-releasing 
effect of glucagone was considered direct 
and independent. 
CONCLUSIONS 
1. A delayed glucose liver release after 
glucagone stimulation is observed in A V H 
patients. 
2. A reduced insulin response to 
glucagone stimulation is established in 
A V H cases. 
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3. The changes in the response to significance of this test as a suitable 
glucagone loading emphasize the approach in liver function evaluation. 
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Analyse der Glykogenreserve in Kranken mit akuter Virushepatitis 
mit Hilfe des Glukagontestes I M. Nenova Lehrstuhl fur infektiose Krankheiten, Medizinische Universitdt Varna Zusammenfassung: Bei 10 Patienten mit akuter Virushepatitis wurde in der akuten Krankheitsphase intravenoser Glukagontest mit einer Bestimmung der Serumglukose und I R I durchgefiihrt. Es stellte sich eine verzogerte Leberglukoseabgabe fest was auf eine gestorte Glykogenolyse (geschadigte Membranstruktur und Enzymefunktion) und verminderte Glykogenreserve deutete. Die Seruminsulinbestimmung ergab eine erniedrigte Intensitat der Antwort auf die Glykagonstimulation. Diese Beftinde wiesen die Notwendigkeit der Durchfuhrung des Glukagontestes, die Leberftinktion wahrend einer akuten Virushepatitis besser zu beurteilen, auf. Analyse du reserve de glucogene par un test au glucagon chez malades d'hepatite virale aigue M. Nenova Chaire des maladies infectieuses, Universite de medecine a Varna Resume: On discute les resultats obtenus par le test au glucagon chez 10 malades d'hepatite virale aigue. On etabli un relentissement de la delivraison de glucose, 
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qui decouvre une glycogenolyse genee (demolissement des structures 
membraneuses et dysfunction enzymatique) et comme une diminuation du niveau 
de glycogene. La reponse insulinaire a la stimulation par glucagone est faible. 
L'etude montre la necessite du test au glucagon pour preciser la fonction du foie 
chez les malades d'hepatite virale aigue. 
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